FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZANDELISIB
异名/同义词1,3,5-TRIAZIN-2-AMINE, 4-(2-(DIFLUOROMETHYL)-1H-BENZIMIDAZOL-1-YL)-N-(1,1-DIMETHYL-2-(2-(1-METHYL-4-PIPERIDINYL)PHENYL)ETHYL)-6-(4-MORPHOLINYL)-
4-(2-(DIFLUOROMETHYL)BENZIMIDAZOL-1-YL)-N-(1,1-DIMETHYL-2-(2-(1-METHYL-4-PIPERIDYL)PHENYL)ETHYL)-6-MORPHOLINO-1,3,5-TRIAZIN-2-AMINE
ACC-524
ME-401
PW-143
PWT143
PWT-143
ZANDELISIB
ZANDELISIB [INN]
ZANDELISIB [JAN]
ZANDELISIB [USAN]
ZANDELISIB [WHO-DD]
CAS登记号1401436-95-0
物质唯一标识(Unique Ingredient Identifier)8Z28M5SX0X
分子式C31H38F2N8O
国际化合物标识(International Chemical Identifier,InChI)WPFUFWIHMYZXSF-UHFFFAOYSA-N
SMILESn1c(nc(nc1N2CCOCC2)NC(Cc3ccccc3C4CCN(CC4)C)(C)C)-n5c(nc6c5cccc6)C(F)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 日本药品名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System